Trials / Conditions / Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
4 registered clinical trials studyying Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell NCT03422536 | University of Arizona | Phase 2 |
| Completed | Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivar NCT02538510 | University of Washington | Phase 1 / Phase 2 |
| Terminated | Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Ne NCT02196168 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D NCT01256385 | National Cancer Institute (NCI) | Phase 2 |